What We're Hearing From Insurance Investors (08/21/2026) Over the past week, P&C investors focused on: (1) Progressive's July 2026 results, (2) CIAB pricing trends, and (3) Allstate and the broader industry's CAT risk. We also share our thoughts on the Moderna/Merck cancer drug's potential impact on the Life insurance side. Potential cancer drug implications. Moderna/Merck cancer drug development news could represent a notable change in cancer treatment. While the treatment is seen as an important step for ...